Retrospective study whether influence to the effect of Osimertinib by the kind of previous EGFR-TKI
Latest Information Update: 24 Aug 2020
Price :
$35 *
At a glance
- Drugs Osimertinib (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 24 Aug 2020 New trial record